Becton, Dickinson & Co. engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Fives Cail provides engineering services. The company is headquartered in Ronchin, France.

MediSense, Inc. was engaged in the development, manufacture, and marketing of self-testing blood glucose monitoring systems that enabled people with diabetes to manage their disease effectively.

Saint-Gobain Isover G+H AG manufactures construction materials. It provides materials for roofs, walls, floors and ceilings. The company also offers insulators and absorbers. The company was founded in 1878 by Dr. Carl Grünzweig and Paul Hartmann and is headquartered in Ludwigshafen, Germany.

LG H&H Co., Ltd. engages in the production and sale of household goods and cosmetic products. It operates through following divisions Beauty, Health and Refreshment businesses. The Beauty business division provides anti-aging cosmetic products. The Health division markets healthcare, skincare and household products. The Refreshment division provides soda, juice, energy drinks and other beverages. The company was founded on April 3, 2001 and is headquartered in Seoul, South Korea.

Part of Becton, Dickinson & Co., Becton, Dickinson & Co. Ltd. is an Irish company located in Dublin. The firm manufactures and supplies medical devices.

FAG Kugelfischer AG & Co. KG specializes in precision and rolling bearings. It manufactures bearings for applications in machine building, automotive industry, aviation and aerospace technology. It's portfolio in rolling bearing industry covers applications in production machinery, power transmission and rail technology, heavy industry and consumer products. It also offers customers support and services for the diagnosis, maintenance and mounting of rolling bearings and complete systems. Founded in 1883, the company is headquartered in Schweinfurt, Germany.

Gambro is a global medical technology company and a leader in developing, manufacturing and supplying products and therapies for Kidney and Liver dialysis, Myeloma Kidney Therapy, and other extracorporeal therapies for Chronic and Acute patients. Kidney (renal) dialysis was the world’s first extracorporeal therapy (i.e. a therapy that treats organ failure outside the body). Dialysis saves the lives of a growing number of patients every year, and innovation in the field is essential. The only current alternative to renal dialysis - kidney transplantation - is not an available option for most patients, due to a shortage of donor organs. Dialysis technology is now being developed for new applications such as liver dialysis and an emerging field of other extracorporeal therapies, to remove different fluids and toxins from chronically and acutely ill patients. For decades, Gambro has been first to market with many groundbreaking innovations. By designing and delivering solutions to dialysis clinics and intensive care units, Gambro offers not just improved treatment quality, but also improved efficiency. Gambro was founded in 1964 and has today 8 000 employees, 13 production facilities in 9 countries, and sales in more than 90 countries.

Siemens Healthcare Diagnostics, Inc. engages in the vitro diagnostics. It provides healthcare professionals in hospital, reference, and physician office laboratories and point-of-care settings with the vital information required to accurately diagnose, treat, and monitor patients. The company is headquartered in Tarrytown, NY.

Nuovo Pignone Divisione SMIT, a subsidiary of Sulzer AG, is a company headquartered in Italy. The firm manufactures weaving machinery. Sulzer AG acquired Nuovo Pignone Divisione SMIT from General Electric Co. on July 17, 1998.

Genetics Institute is a U.S. based biotechnology research and development company. The company developed drugs such as Neumega and Recombinate used in the prevention of severe reductions in the number of blood clotting cells. The company was founded in 1980 by Thomas Maniatis and Mark Ptashne, and started off by operating out of Ptashne’s home. Genetics Institute was acquired by Wyeth in 1992 and operates as part of Wyeth’s research division.

BASF Corp. manufactures commercial and industrial chemicals. The firm serves the aerospace, agriculture, automotive, clean energy, nutrition, textiles, and building, and construction sectors. The company was founded in 1986 and is headquartered Florham Park, NJ.

Hayashibara Biochemical Laboratories, Inc. manufactures food and cosmetic products. It also makes health food ingredients, functional dyes, and reagents. The company was founded in 1970 and is headquartered in Okayamashi, Japan.

R&D Systems is a product and services agency bringing together resources for Cell Biology research. On February 10, 2014, Techne Corporation, R&D Systems parent company, announced that it will be operating under the new trade name, Bio-Techne. The use of Bio-Techne will bring the company’s R&D Systems, BiosPacific, Tocris Biosciences, Boston Biochem and Bionostics products under one common brand name. For more information on Bio-Techne please visit bio-techne.com. R&D Systems, a Minnesota-based biological products company, started by producing hematology controls and calibrators for use in hospitals and clinics. In 1977, we introduced our first product, a platelet-rich-plasma control, and in 1981, we became the second manufacturer in the world to release a whole blood control with platelets. Over the years, R&D Systems Hematology has continued to develop a variety of hematology controls. These products continue to be available through our Clinical Controls Division. In 1985, we released our first research reagent, TGF-beta 1, becoming the first company in the world to produce this cytokine commercially. TGF-beta 1 acts as an extracellular signaling molecule that is produced by many cell types. It is involved in such processes as immune function, cell proliferation, and cell differentiation. Following the launch of this product, we purified several other cytokines from natural sources and released them to the research market. Of great interest to biomedical researchers, cytokines are specialized proteins mediating communication between cells. They have many biological activities including regulating developmental processes and orchestrating the immune response. In addition, unregulated cytokine activity has been linked to many diseases including cancer, cardiovascular disease, and inflammatory disorders. Encouraged by success in the cytokine market, we formed the Growth Factor (now known as Biotechnology) Division in 1985 with the goal of producing and marketing a wide range of human cytokines through genetic engineering. Recombinant DNA technology offers several advantages over extraction of these proteins from natural sources, including lower production cost and potentially unlimited supply. In 1989, the Biotechnology Division began developing monoclonal and polyclonal antibodies to cytokines, and in 1990 we developed our first enzyme-linked immunosorbent assay (ELISA) kit. Currently, R&D Systems, Tocris Bioscience, and Boston Biochem will serve as the flagship brands in Bio-Techne's life science portfolio. In the coming months a new corporate identity, including new packaging, new literature, new trade show booth, as well as a new unified website will be introduced to customers.

Terumo BCT, Inc. develops and provides blood component and cellular technologies with the combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company offers products in the areas of apheresis collections, therapeutic apheresis, cell therapy systems, and whole blood processing and pathogen reduction technologies. Its products include information systems, data collection systems, apheresis systems, pathogen reduction technology systems, whole blood processing systems, orbisac systems, cell expansion systems, IIB sterile tubing welders, blood bags, and blood bag systems. The company was founded by Robert Collins\nand Randall Bellows in 1964 and is headquartered in Lakewood, CO.